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Abstract
Objective—To evaluate the association of low socioeconomic status as an independent risk factor 
for unintended pregnancy.
Methods—We performed a secondary analysis of data from the Contraceptive CHOICE project. 
Between 2007 and 2011, 9,256 participants were recruited and followed for up to 3 years. The 
primary outcome of interest was unintended pregnancy; the primary exposure variable was low 
socioeconomic status, defined as self-report of either receiving public assistance or having 
difficulty paying for basic necessities. Four contraceptive groups were evaluated: 1) long-acting 
reversible contraceptive method (hormonal or copper intrauterine device (IUD) or subdermal 
implant) users; 2) depot medroxyprogesterone acetate injection; 3) oral contraceptive pills, a 
transdermal patch, a vaginal ring; or 4) other or no method. Confounders were adjusted for in the 
multivariable Cox proportional-hazard model to estimate the effect of socioeconomic status on risk 
of unintended pregnancy.
Results—Participants with low socioeconomic status experienced 515 unintended pregnancies 
during 14,001 women-years of follow-up (3.68 per 100 women-years; 95% CI: 3.37–4.01]), 
compared to 200 unintended pregnancies during 10,296 women-years (1.94 per 100 women-years; 
95% CI: 1.68–2.23]) among participants without low socioeconomic status. Women with low 
socioeconomic status were more likely to have an unintended pregnancy (unadjusted hazard ratio 
(HR) = 1.8 [95% CI: 1.5–2.2]. After adjusting for age, education level and insurance status, low 
socioeconomic status was associated with an increased risk of unintended pregnancy (adjusted 
hazard rate ratio = 1.4 [95% CI: 1.1–1.7])
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CONCLUSION—Despite the removal of cost barriers, low socioeconomic status is associated 
with a higher incidence of unintended pregnancy.
INTRODUCTION
Unintended and unplanned pregnancies are perplexing public health problems that are 
associated with higher rates of poor maternal and child health outcomes as well as an annual 
public cost of over $21 billion in the United States.(1,2) Despite decades of study and 
proposed interventions, the percentage of pregnancies that are mistimed or unwanted 
remains between 45 and 50%.(1,3,4) Increased use of long-acting reversible contraception 
(LARC), intrauterine devices (IUDs) and the contraceptive implant, can have a profound 
impact on the rates of unintended pregnancies and abortions and may help reduce health 
disparities. (5,6,7,8)
Unfortunately, some women and couples at greatest risk of unintended pregnancy are least 
likely to have access or means to afford the most effective contraceptive methods. Even with 
the provision of no-cost contraception through the Affordable Care Act (ACA), the rates of 
unintended pregnancy remain high.(4,9) Differential implementation of the ACA and 
expansion of Medicaid has resulted in many remaining uninsured and lacking contraceptive 
access. Socioeconomic status may be an essential characteristic to consider as a risk factor 
for unintended pregnancy. In addition, other demographic characteristics such as young age, 
black race, and lower educational level may also be associated with higher rates of 
unintended pregnancy. These factors are associated with informational barriers and a culture 
of social norms and attitudes regarding childbearing, pregnancy and contraceptive use that 
contribute to contraceptive behaviors.(10,11)
Data from the Contraceptive CHOICE Project (CHOICE) were used to assess and quantify 
risk factors associated with unintended pregnancy in a diverse cohort of women with access 
to no-cost contraception. We hypothesized that low socioeconomic status is an independent 
risk factor for unintended pregnancy, even after controlling for other potential confounders 
including demographic and reproductive characteristics, and contraceptive method use.
MATERIALS AND METHODS
The Contraceptive CHOICE Project is a prospective cohort study of 9,256 participants in the 
St. Louis region; this is a secondary analysis of the CHOICE database. The methods of the 
Contraceptive CHOICE Project have been described in numerous publications.(5,6) 
Between 2007 and 2011, we recruited 9,256 participants into an observational study to 
assess contraceptive choice, continuation, and satisfaction with contemporary methods of 
contraception. To enroll in the study, women had to: 1) live in the St. Louis region; 2) be 
sexually active with a male partner (or intend to be); 3) speak English or Spanish; 4) desire 
to avoid conception for at least 12 months; and 5) be willing to start a new contraceptive 
method. Women were excluded if they: 1) refused telephone follow-up; 2) were unwilling to 
consent; or 3) were sterile or desired sterilization. Prior to initiating the study, the project 
was approved by the Washington University in St. Louis Institutional Review Board.
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At baseline, we collected demographic information including age, race, ethnicity, 
educational level, income, need for public assistance, and other markers of socioeconomic 
status (defined as self-report of either receiving public assistance or having difficulty paying 
for basic necessities such as food and housing). Reproductive information included 
gravidity, parity, history of sexually transmitted infections (i.e. bacterial or viral), and history 
of unintended pregnancy. We also collected information regarding tobacco and drug abuse, 
sexual history, and baseline choice of contraceptive method in the Contraceptive CHOICE 
Project.
All participants were followed longitudinally with telephone surveys at 3, 6, 12 months, and 
every 6 months for the duration of participation. Our first group of approximately 5,000 
participants were followed for 3 years, while the remainder of the cohort was followed for 2 
years. All contraceptive methods were provided at no cost to participants for the duration of 
their participation. In addition, women could change their contraceptive method at any time 
during their participation.
This analysis included all 9,256 participants. We measured segments of contraceptive 
method use by each woman throughout study participation. Information about method start 
and stop dates was collected from three sources: scheduled telephone interviews; pharmacy 
data obtained from the partner pharmacy where participants obtained pills, patch, or ring; 
and the participant contraceptive-method log that documented when the participant initiated 
or discontinued use of a method or switched to another method (i.e., insertion or removal of 
an IUD or implant; receipt of an initial pill supply, patch, or ring; and depot 
medroxyprogesterone acetate (DMPA) injection). A participant was considered to have used 
DMPA for the 16-week interval after a record of an injection, based on the World Health 
Organization recommendation. If participants switched methods during the study, they 
contributed distinct segments to multiple methods. Contraceptive methods were grouped as 
follows: 1) long-acting reversible contraception (LARC) included the hormonal or copper 
IUD and the subdermal implant; 2) depot medroxyprogesterone acetate (DMPA) injection; 
3) oral contraceptive pills, a transdermal patch or a vaginal ring; and 4) other. An “other” 
category was created for participants that were using any contraceptive methods other than 
the seven methods mentioned above. For example, if participants used condoms or another 
barrier method (e.g. diaphragm), coitus interruptus, natural family planning, or reported no 
method, they were grouped into the “other” contraceptive category.
Our primary outcome for this analysis was unintended pregnancy, which was assessed at 
each follow-up phone surveys. Participants were asked about the possibility of pregnancy 
and missed menstruation at each follow up. If there was a chance that a participant was 
pregnant, she was asked to return to the clinic for a urine pregnancy test. If the pregnancy 
test was positive, the date of the last menstrual period was used to calculate the conception 
date. A pregnancy log sheet was used to collect data on all the pregnancies reported during 
the study and an unintended pregnancy was defined as a conception that participant reported 
as “not intended.” If a participant had multiple unintended pregnancies during her time in 
the study, we only account for the segments of method use prior to the first unintended 
pregnancy. If a participant reported an intended pregnancy or reported having stopped 
contraceptive method trying to conceive, then her segment of method use was censored at 
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the time of intended pregnancy or when she stopped contraceptive method for desire of a 
pregnancy.
To describe the demographic characteristics of the study participants, means, standard 
deviations, frequencies, and percentages were used depending on the data type. Participants 
were grouped by their chosen method at enrollment into one of the following method 
groups: LARC (IUDor implant), DMPA and contraceptive pills, patch, or ring. For the 
comparison among participants with different baseline chosen method, ANOVA was used 
for normally distributed continuous variables, and chi-square test was performed for 
categorical variables.
Our primary exposure variable was low socioeconomic status, defined as self-report of either 
receiving public assistance or having difficulty paying for basic necessities. Cox 
proportional-hazard models were used to estimate the hazard ratios for unintended 
pregnancy. Clustering of variance–covariance estimation methods were used to account for 
the effect of correlation among different segments of contraceptive use from the same 
participant. Demographic (i.e., age, race, educational level, income and insurance), and 
reproductive characteristics (history of unintended pregnancy, history of abortion, history of 
sexually transmitted infections (STI) and current STI at enrollment(Neisseria gonorrhoeae, 
Chlamydia trachomatis, Trichomonas vaginalis), and contraceptive methods were evaluated 
for potential confounding effect in the association between socioeconomic status and 
unintended pregnancy. Confounding was defined as a greater than 10% relative change in 
the association between socioeconomic status and risk of unintended pregnancy with or 
without the potential confounding covariate in the model. Confounders were included in the 
final multivariable model. All the statistical analyses were performed using Stata software, 
version 11 (StataCorp). The significance level (alpha) was set at 0.05.
The sample size for the Contraceptive CHOICE Project was adequate to address the specific 
research question in this analysis. The sample provides > 90% power to detect a 40% 
increase in unintended pregnancy in women of low socioeconomic status compared to 
participants not meeting our low socioeconomic status definition (with an alpha 
(significance) level of 0.05).
RESULTS
The baseline characteristics of the study population are shown in Table 1. The mean age of 
the participants was 25 years; 50% were black, 35% have less than high school education, 
58% were considered low socioeconomic status. Over 40% of participants were uninsured, 
63% experienced at least one unintended pregnancy, 35% had an abortion, and 40% have a 
history of a STI. Eight percent of participants were found to have an STI at baseline.
Table 1 also compares demographic and reproductive characteristics by choice of 
contraceptive method at enrollment: LARC, DMPA, or pills, patch, and vaginal ring (PPR). 
LARC users were slightly older, more likely to be overweight or obese, have higher 
gravidity/parity, and more likely to have a previous unintended pregnancy. DMPA users 
were more likely to be black, have a previous or current STI, and to have history of abortion. 
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Pills, patch, and ring users were younger, have a higher level of education and 
socioeconomic status, more likely to be privately insured, low parity, less likely to have a 
history of unintended pregnancy, abortion, or STI, and less likely to have a current STI.
In our analysis, there were total of 1000 pregnancies reported, among which 716 (71.6%) 
were unintended pregnancies over the 2–3 years of follow-up. Participants with low 
socioeconomic status experienced 515 unintended pregnancies during 14,001 women years 
(3.68 per 100 women-years; 95% confidence interval (CI): 3.37–4.01]), compared to 200 
unintended pregnancies during 10,296 women years (1.94 per 100 women-years; 95% CI: 
1.68–2.23]) among participants without low socioeconomic status. Women with low 
socioeconomic status were more likely to have an unintended pregnancy (unadjusted hazard 
ratio = 1.8 [95% CI: 1.5–2.2]. Demographic and reproductive factors associated with 
unintended pregnancy in the univariable analysis included age, race, educational level, 
insurance, gravidity, parity, history of unintended pregnancy and abortion, history of STI, 
and positive STI at enrollment. Contraceptive method was also a significant risk factor in our 
univariable analysis. These factors were further evaluated for confounding effect in the 
association between socioeconomic status and unintended pregnancy, and Table 2 contains 
the final multivariable model after adjusting for confounders. After adjusting for age, 
education level and insurance status, low socioeconomic status was associated with an 
increased risk of unintended pregnancy (adjusted hazard rate ratio = 1.4 [95% CI: 1.1–1.7]).
DISCUSSION
In our analysis of over 700 unintended pregnancies in the Contraceptive CHOICE Project, 
low socioeconomic status was associated with an increased incidence of unplanned 
pregnancy, even when no-cost contraception has been provided. Our results also indicate that 
demographic factors such as young age (under 20 years), low educational level, and a history 
of unintended pregnancy were associated with unplanned pregnancy in our sample. 
Furthermore, as shown in previous studies, use of a LARC method (IUD or implant) was 
highly protective. These results highlight socioeconomic status as an important independent 
risk factor for unintended pregnancy. It is interesting that socioeconomic status was still 
associated with a higher rate of unintended pregnancy, even after financial barriers to 
contraceptive provision were removed. This finding may be attributed to user error, issues 
with method adherence, misunderstanding due to lower educational level, or gaps in 
contraceptive method use.
The medical literature supports our findings of the association of low socioeconomic status 
and unintended pregnancy. Despite an overall decrease in the rates of unintended pregnancy 
in the U.S. from 1994 to 2001 and from 2008 to 2011, there was a consistent rise in the rates 
among the poorest women (below 100% of the poverty level) and a significantly increased 
rate compared to women of higher socioeconomic status. (4,12) The poorest women are four 
to five times more likely than women living at 200% of the poverty line or higher to have an 
unintended pregnancy. (3,12) Reasons for this disparity may be attributed in part to the link 
between low socioeconomic status and low educational level. However, we found 
socioeconomic status to be a risk factor even after controlling for education. Other studies 
have shown that women with the fewest years of education (less than college), had the 
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highest incidence of unintended pregnancy.(3,4,11) Rates of unintended pregnancy tends to 
decrease as years of education attained increases.(3,4,11)
Young age is another important risk factor for unintended pregnancy that is supported by the 
medical literature. Studies indicate that even with an overall decrease in unintended 
pregnancy between 2008 and 2011, young women 18 to 29 years of age have the highest rate 
of unintended pregnancy. While teenagers age 15–18 have seen a decrease in unintended 
pregnancy rates over the past 20 years, the rate in this age group is still double that of adult 
females.(1,4,10,11,13) Many young adults and adolescents have limited contraceptive 
knowledge, restricted access to contraceptives and exhibit conflicting and ambivalent 
attitudes about pregnancy and contraceptive use. This creates a situation where most young 
adults are not trying to get pregnant, but are not taking the necessary precautions to avoid 
unintended pregnancy.(10,14,15) As Isabel Sawhill writes in her book, Generation Unbound, 
more and more young people are “drifting” into parenthood, rather than planning 
pregnancies. The result of which may lead to increased poverty, inequality, and health 
disparities.(16)
The use of a LARC has been shown in several studies to reduce rates of unintended 
pregnancy more effectively than other contraceptive methods. (5,7) The American College 
of Obstetrics and Gynecologists, the American Academy of Pediatrics and the Centers for 
Disease Control and Prevention (CDC) have all recommended that LARC methods should 
be offered as first line methods of contraception for women of various age groups, parity, 
age and physical characteristics. (17,18,19,20) Several studies have illustrated that when 
barriers to cost, access and knowledge are removed, black-white disparities in unintended 
pregnancy among sexually active teens and women were reduced.(5,15,21) By adapting a 
client-centered approach for counseling teens and women, ensuring the most effective 
contraceptive methods are discussed with each patient, and adapting programs to help 
subsidize the provision of these methods, it is possible that unintended pregnancy rates 
across all ages, ethnic and socioeconomic statuses will continue to decline.(7,8,15)
Previous unintended pregnancy belongs to a collection of high risk behaviors that may be 
contributing factors to the high rate of unintended pregnancy.(22) Data suggest that women 
who partake in high risk behaviors such as early onset coitus, coitus with multiple sexual 
partners, and failure to use barrier contraception may have a higher risk of unintended 
pregnancy and acquiring an STI.(17,23)
The strengths of our study include the prospective design of the Contraceptive CHOICE 
Project, the large, economically and ethnically diverse cohort, and a population of women 
who were at high risk for unintended pregnancy. In addition, this report contains a large 
number of unintended pregnancies (over 700) in a dataset with individual-level demographic 
and reproductive data. There are few prospective studies in the medical literature that 
simultaneously examine socioeconomic status, other demographic and reproductive 
characteristics, contraceptive method use and the risk of unintended pregnancy. One 
limitation of this project is generalizability. The CHOICE population contained a 
disproportionately high representation of black (51%) and low socioeconomic status (58%) 
participants than the U.S. population (12.3% black), and was limited geographically to the 
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St. Louis region. Our inclusion criteria that required participants to try a new contraceptive 
method also may limit generalizability.
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